SIG
52
5
TEL
72
-2
EW
57
7
EBAY
48
-4
FTI
60
-18
HD
31
-3
LH
48
-2
NWL
58
-2
KIM
51
-3
T
27
-2
HRL
30
-5
MMM
54
-3
RRC
59
-4
OI
50
-6
ETR
52
-3
FRT
58
-2
ITW
37
-6
LEG
58
-4
KHC
29
2
HAL
47
-6
SIG
52
5
TEL
72
-2
EW
57
7
EBAY
48
-4
FTI
60
-18
HD
31
-3
LH
48
-2
NWL
58
-2
KIM
51
-3
T
27
-2
HRL
30
-5
MMM
54
-3
RRC
59
-4
OI
50
-6
ETR
52
-3
FRT
58
-2
ITW
37
-6
LEG
58
-4
KHC
29
2
HAL
47
-6
Financhill
Back

KraneShares Emerging Markets Consumer Tech Idx ETF Vs. Nektar Therapeutics Industry Stock Comparison

Buy
54

KEMQ
KraneShares Emerging Markets Consumer Tech Idx ETF

Last Price:
$25.25
Seasonality Move:
-0.05%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$44.95
Seasonality Move:
11.58%
Buy
54
KraneShares Emerging Markets Consumer Tech Idx ETF (KEMQ) is a Buy

Is KraneShares Emerging Markets Consumer Tech Idx ETF a Buy, Sell or Hold?

  • The current KraneShares Emerging Markets Consumer Tech Idx ETF [KEMQ] share price is $25.13. The Score for KEMQ is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • KEMQ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KEMQ Stock Price Chart

What is KraneShares Emerging Markets Consumer Tech Idx ETF's stock price today?

  • The KraneShares Emerging Markets Consumer Tech Idx ETF share price today is $25.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KEMQ is experiencing buying pressure, which is a positive indicator for future bullish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

KEMQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 38.56 Sell
Chaikin Money Flow: 5398 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

KEMQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.7 Sell
20-day SMA: 25.62 Sell
50-day SMA: 26.16 Sell
200-day SMA: 22.69 Buy
8-day EMA: 25.55 Sell
20-day EMA: 25.75 Sell
50-day EMA: 25.36 Sell
200-day EMA: 15.95 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

KraneShares Emerging Markets Consumer Tech Idx ETF Earnings Growth & KEMQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

KraneShares Emerging Markets Consumer Tech Idx ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):